Iron may be a factor in dementia

February 17, 2015 by Leigh Dayton
Iron may be a factor in dementia
Dr Dominic Hare at work in his laboratory. Credit: George Ganio

Alzheimer's disease is no respecter of fame or fortune. Former US president Ronald Reagan had it. Legendary AC/DC guitarist Malcolm Young has been diagnosed. Hazel Hawke suffered until her death in 2013. And author and broadcaster Anne Deveson is experiencing the distressing progression of Alzheimer's, the most common form of dementia, a group of brain disorders affecting thinking and memory.

There is no way to spot Alzheimer's early, no effective treatment and no known cure. However, a neurochemist at the University of Technology, Sydney (UTS), Dr Dominic Hare, and his colleagues are homing in on a biomarker, or disease indicator, to help diagnosis.

Moreover, Dr Hare – who is also with the Florey Institute of Neuroscience and Mental Health in Melbourne and the Icahn School of Medicine at Mount Sinai in New York City – says the team's work promises to help reveal the cause of the baffling disorder.

"The disease develops so slowly and has so many effects on the body, being able to separate what's cause and what's effect is a big problem," he says. "If we can identify why the disease is happening, we could intervene to alleviate the symptoms and potentially halt the disease process."

At present, a diagnosis of Alzheimer's disease is made only after careful clinical consultation, and any diagnosis can be confirmed only by examining the brain after death.

However, Dr Hare and his co-workers are not looking in the brain for clues. They're looking in the blood. In a recent article in the US journal ACS Neuroscience, the group outlined its work with a potential biomarker and a possible causative culprit: .

"The body uses metals like copper, zinc and iron to facilitate biochemical reactions it wants. In the case of disease, these are reactions that are unwanted," Dr Hare says, adding that iron plays a very important role in the ageing process, and ageing is the key risk factor for Alzheimer's disease. One in four people over the age of 85 have dementia; 75 per cent of those have Alzheimer's.

Professor Perminder Sachdev, co-director of the Centre for Healthy Brain Ageing at the University of NSW, says metals have previously been linked to Alzheimer's but the findings were inconclusive.

"This study by Dr Hare and his colleagues is, therefore, of interest to researchers in the field," says Professor Sachdev, chief medical adviser to Alzheimer's Australia.

Specifically, Dr Hare's team is studying transferrin, a protein that helps ferry iron around the body. In the case of Alzheimer's, if transferrin falls down on the job iron may accumulate in the brain, where it contributes to the build-up of "plaques" and "tangles". Plaques impede the transmission of signals among brain cells and tangles kill them.

To track transferrin's activity, Dr Hare teamed up with Dr Blaine Roberts, head of the Metalloproteomics Laboratory at the Florey Institute. They designed the research using blood samples collected for the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).

The multi-disciplinary, multi-institutional project is one of world's largest studies of the biomarkers, cognitive characteristics and lifestyle factors implicated in Alzheimer's.

"The unique thing about AIBL is that it's following 1000 people through time," Dr Hare says. "That gives us statistical power." Participants provide blood samples and are tracked over 54 months.

Dr Hare, Dr Roberts and their colleagues used samples from 34 AIBL participants and 36 healthy participants. They employed specialised equipment to analyse samples: an inductively coupled plasma-mass spectrometer (ICP-MS), and a size exclusion chromatography-inductively coupled plasma-mass spectrometer (SEC-ICP-MS).

The results revealed, first, that compared to healthy volunteers, participants with Alzheimer's had lower levels of iron in their plasma, a condition linked with anaemia of unknown cause.

Intriguingly, results from the ICP-MS and SEC-ICP-MS tests, showed healthy and Alzheimer's participants had the same amount of transferrin in their blood but that the amount of iron carried by the transferrin was lower in Alzheimer's samples. The implication: transferrin isn't shuttling excess iron efficiently from the brain.

"The next step is to look at a copper-binding protein called ceruloplasmin that interacts with transferrin," says Dr Hare. "Putting all these pieces together will help find methods to maintain quality of life, possibly slowing or even halting the progress of the disease."

Explore further: Biotech company develops way to carry antibodies across blood-brain barrier to treat Alzheimer's

Related Stories

Research could lead to Alzheimer's drugs

February 6, 2015

New insights into how nerves cells in the brain maintain efficient communication with each other may help offset the effects of Alzheimer's disease.

Recommended for you

Plant reveals anti-Alzheimer's compounds

June 20, 2017

Japanese scientists have developed a method to isolate and identify active compounds in plant medicines, which accurately accounts for drug behavior in the body. Using the technique, they have identified several active compounds ...

Rate of Alzheimer's deaths on the rise

June 15, 2017

The rate of death from Alzheimer's disease in the United States increased by more than 50 percent in the past 15 years, according to new data from the Centers for Disease Control and Prevention.

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

deesund
not rated yet Feb 17, 2015
When anyone is diagnosed with Alzheimers, the most important thing you can do is to be certain the diagnosis is accurate. I cared for people in their homes for fifteen years. The husband of one patient began asking me the same questions repeatedly. I usually accompanied them to doctor appointments, but this time they went alone. Bill was promptly diagnosed with early onset Alzheimers. When I came to their home, their eyes were swollen from crying. I told them not to panic. I phoned ACAM [American College of Alternative Medicine].]. We lived in Southern Oregon and was fortunate to find a doctor in Portland. This is a man who could think 'out of the box'. After talking to Bill for about five minutes, he told him that he was quite certain that he didn't have Alzheimers. He said that he could run lots of expensive time consuming tests, but with his permission, he would like to go with his 'gut feeling'. He prescribed LTryptophan and in three weeks, Bill was back to normal.
Melmac
not rated yet Feb 18, 2015
deesund....I would like to ask you some questions if possible. The repeated questions is what I'm interested in and what about the conversation with the doctor made him feel it wasn't Alzheimer's. If you can post to this site again I will give you my email address. Please help.
yvchawla
Feb 23, 2015
This comment has been removed by a moderator.
Melmac
not rated yet Feb 23, 2015
yvchawla...I'm so glad you cleared that up! For those of us wanting REAL help....we'll keep looking.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.